- Home
- HIMS
as 06-03-2025 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $37.67 | AVG Volume (30 days): | 55.8M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.47 - $72.98 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,784,353,000 | Revenue Growth: | 85.99% |
| Revenue Growth (this year): | 62.48% | Revenue Growth (next year): | 20.34% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew | HIMS | Chief Executive Officer | May 16 '25 | Sell | $58.61 | 175,661 | $10,251,387.69 | 148,380 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | May 15 '25 | Sell | $60.22 | 11,581 | $697,462.25 | 113,816 | |
| Boughton Soleil | HIMS | Chief Legal Officer | May 12 '25 | Sell | $56.00 | 3,235 | $181,160.00 | 156,427 | |
| Baird Melissa | HIMS | Chief Operating Officer | May 12 '25 | Sell | $56.38 | 33,333 | $1,867,376.22 | 817,829 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Apr 28 '25 | Sell | $33.29 | 91,667 | $3,077,070.06 | 148,380 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Apr 28 '25 | Sell | $30.19 | 3,236 | $97,694.84 | 156,427 | |
| Becklund Irene | HIMS | PAO | Apr 22 '25 | Sell | $26.49 | 2,936 | $77,774.64 | 5,071 | |
| Baird Melissa | HIMS | Chief Operating Officer | Apr 21 '25 | Sell | $25.97 | 33,333 | $859,256.11 | 817,829 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Apr 16 '25 | Sell | $28.19 | 83,994 | $2,364,547.13 | 148,380 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Apr 15 '25 | Sell | $28.50 | 11,581 | $330,081.66 | 113,816 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Investor's Business Daily
16 hours ago
IBD 50's Hims & Hers Health Shoots Higher On A Key Takeover In Europe
Business Wire
17 hours ago
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
Newsfile
5 days ago
Sienna Resources Inc. Announces Private Placement
Energy Global
5 days ago
European Energy completes sale of Polish wind portfolio to Enea Group
Newsfile
5 days ago
Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit
Newsfile
5 days ago
Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025
Yahoo Personal Finance
5 days ago
First Foundation Bank review (2025): Personal and business banking with competitive online rates
Investing.com
5 days ago
Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.